Navigation Links
Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection

illennium.com/">http://www.millennium.com.

This press release contains "forward-looking statements," including statements about the Company's growth and research and development of products. Various important risks may cause the Company's actual results to differ materially from the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. For a further list and description of the risks and uncertainties the Company faces, see the reports it has filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

    Contacts:

    Kyle Kuvalanka (investors)               Jennifer Snyder (media)

    (617) 761-4734                           (617) 444-1439


    

CONTACT: Investors: Kyle Kuvalanka, +1-617-761-4734, or Media: JenniferSnyder, +1-617-444-1439, both of Millennium Pharmaceuticals, Inc.

Web site: http://www.millennium.com/

Ticker Symbol
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
2. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
3. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
4. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
5. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
6. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
7. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
8. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
9. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
10. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
11. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
Post Your Comments:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... , , BURLINGTON, ... of events at the Cardiovascular Research Foundation,s (CRF) annual Transcatheter ... to Friday, September 25th, in San Francisco, CA. at the ... largest events for those performing cardiac diagnostics and interventions. ...
... , ROCHESTER, Minn., Sept. 11 A Mayo Clinic ... good central nervous system repair in multiple sclerosis (MS). These findings ... with MS and for predicting MS patients, outcomes. This study will ... and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, ...
Cached Medicine Technology:InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 3
(Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... identified the first genetic variant specifically associated with ... for around 10-15 per cent of all breast ... the breast cancer sub-type, called invasive lobular carcinoma, ... of this particular kind of breast cancer, which ... published today (Thursday) in the journal PloS ...
(Date:4/17/2014)... to a study published today in PLOS Pathogens ... where malaria is common can mount an immune response ... to avoid repeated bouts of high fever and illness ... their bloodstream. The findings may help researchers develop future ... the malaria parasite. , Each year, approximately 200 million ...
(Date:4/17/2014)... recent papers by a University of Colorado School ... develop treatments or vaccines for Dengue fever, West ... disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, associate ... School of Medicine and an early career scientist ... recently published articles in the scholarly journals ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... with sound advice may help them identify hearing loss ... therefore untreated. ,Hearing loss in children often remain ... and lead to deficiency in attending, difficulty in attending ... to the researcher Judith Gravel from The Children's Hospital ...
... Adjuvant chemotherapy with epirubicin and cyclophosphamide for early ... myeloid leukemia or Myelodysplastic syndrome. ,Recent study ... early breast cancer patients undergoing chemotherapy with higher ... have an increased risk of developing Acute myeloid ...
... Heidelberg in Mannheim, concludes that women appear to develop alcoholic ... that women become dependant on alcohol not as frequently as ... on the general alcohol consumption pattern if men and women. ... and before pregnancy. It might have adverse effects on the ...
... plays an important role in increasing death risk.// It is ... that can kill him. ,Depression had long been taken ... disease. Now the team of researchers from Washington University School ... rate variability is the prime cause for such a case. ...
... sterols might help to lower your "bad" LDL cholesterol ... been shown to block cholesterol's absorption, lower blood cholesterol ... intestines. , ,The study had 29 participants, all ... type 2 diabetes and were slightly overweight. Participants were ...
... popular form of ancient Indian exercise and meditation for the ... healing properties and is popularly used to relieve people of ... trauma and anxiety in patients with breast cancer., ... Yoga therapy treated over 400 patients with breast cancer with ...
Cached Medicine News:Health News:High-Dosage of Epirubicin and Cyclophosphamide may cause AML 2Health News:Yoga Can Be Good For Breast Cancer Patients 2
... ADVIA Urinalysis WorkCell System - ... 90 tests per hour, with true ... integration of Clinitek Atlas and UF-100 ... highly regarded systems working together deliver ...
... one of the 3 major naturally occurring ... In terms of estrogenic activity, estriol is ... is produced almost exclusively during pregnancy, and ... normal human fetus. During pregnancy, the production ...
... Estrone Sulfate (E1S) is the most ... well as normal men [1,2]. Estrone Sulfate ... estrone, and has a longer half-life in ... levels generally parallel those of estrone and ...
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
Medicine Products: